| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Aminopurvalanol A |
AMINOPURVALANOL A |
220792-57-4 |
详细
|
| Raf inhibitor 2 |
220904-99-4 |
220904-99-4 |
详细
|
| JH-XI-10-02 |
JH-XI-10-02 |
2209085-22-1 |
详细
|
| SU0268 |
[1,1'-Biphenyl]-3-carboxamide, 4'-[[[1-(cyclopropylcarbonyl)-1,2,3,4-tetrahydro-7-quinolinyl]amino]sulfonyl]- |
2210228-45-6 |
详细
|
| Belotecan |
罗汉松双黄酮A |
22136-74-9 |
详细
|
| CD73-IN-4 |
化合物CD73-IN-4 |
2216764-29-1 |
详细
|
| Dazcapistat |
N-(4-AMINO-3,4-DIOXO-1-PHENYLBUTAN-2-YL)-4-(2-FLUOROPHENYL)-2-METHYLOXAZOLE-5-CARBOXAMIDE |
2221010-42-8 |
详细
|
| BC1618 |
化合物BC1618 |
2222094-18-8 |
详细
|
| Cyclic-di-GMP disodium |
CYCLIC DI-GMP SODIUM |
2222132-40-1 |
详细
|
| YTX-465 |
YTX-465 |
2225824-53-1 |
详细
|
| Dynapyrazole-A |
DYNAPYRAZOLE A |
2226517-75-3 |
详细
|
| ELOVL1-IN-1 |
化合物ELOVL1-IN-1 |
2227482-41-7 |
详细
|
| WM-3835 |
化合物WM-3835 |
2229025-70-9 |
详细
|
| TL13-12 |
TL13-12 |
2229037-04-9 |
详细
|
| TL13-112 |
TL13-112 |
2229037-19-6 |
详细
|
| ZL0454 |
ZL0454 |
2229042-77-5 |
详细
|
| FLT3-IN-3 |
SAN50900 |
2229050-90-0 |
详细
|
| MS4077 |
MS4077 |
2230077-10-6 |
详细
|
| XPC-6444 |
XPC-6444 |
2230144-21-3 |
详细
|
| VB124 |
VB-124 |
2230186-18-0 |
详细
|
| Safimaltib |
1H-Pyrazole-4-carboxamide, 1-(1,2-dihydro-1-oxo-5-isoquinolinyl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)-4-pyridinyl]- |
2230273-76-2 |
详细
|
| ZL0590 |
化合物ZL0590 |
2230496-99-6 |
详细
|
| AP1867-2-(carboxymethoxy) |
FKBP12 LIGAND |
2230613-03-1 |
详细
|
| EHMT2-IN-1 |
EHMT2-IN-1 |
2230849-55-3 |
详细
|
| INCB086550 |
INCB084550 |
2230911-59-6 |
详细
|
| NCT-505 |
NCT-505 |
2231079-74-4 |
详细
|
| NCT-506 |
NCT-506 |
2231098-99-8 |
详细
|
| IDH1 Inhibitor 1 |
IDH1 INHIBITOR 1 |
2234285-81-3 |
详细
|
| ONO-4817 |
N-[(1S,3S)-1-[(ETHOXYMETHOXY)METHYL]-4-(HYDROXYAMINO)-3-METHYL-4-OXOBUTYL]-4-PHENOXYBENZAMIDE |
223472-31-9 |
详细
|
| EZH2-IN-2 |
EZH2-A€IN-A€2 |
2238821-31-1 |
详细
|
| Londamocitinib |
JAK1-IN-7 |
2241039-81-4 |
详细
|
| Bemnifosbuvir hemisulfate |
AT-527 |
2241337-84-6 |
详细
|
| JNJ4796 |
JNJ4796 |
2241664-16-2 |
详细
|
| BTK inhibitor 10 |
BTK inhibitor 10 |
2241732-30-7 |
详细
|
| CMPD-39 |
化合物USP30 INHIBITOR 18 |
2242582-40-5 |
详细
|
| BMS-986299 |
BMS986299 |
2242952-69-6 |
详细
|
| WEE1-IN-5 |
化合物DEBIO-0123 |
2243882-74-6 |
详细
|
| Alloxan hydrate |
阿脲一水合物 |
2244-11-3 |
详细
|
| STING-IN-3 |
化合物C-171 |
2244881-69-2 |
详细
|
| CDK12-IN-2 |
化合物CDK12-IN-2 |
2244987-03-7 |
详细
|
| HeE1-2Tyr |
化合物HEE1-2TYR |
2245195-67-7 |
详细
|
| MERS-CoV-IN-1 |
化合物MERS-COV-IN-1 |
2245697-92-9 |
详细
|
| DI-591 |
DI-591 |
2245887-38-9 |
详细
|
| CAY10746 |
CAY10746 |
2247240-76-0 |
详细
|
| BAY-6035 |
BAY-6035 |
2247890-13-5 |
详细
|
| SN-008 |
化合物SN-008 |
2249106-01-0 |
详细
|
| IDRA 21 |
7-氯-3-甲基-3,4-二氢-2H-1,2,4-苯并噻二嗪 1,1-二氧化物 |
22503-72-6 |
详细
|
| Cathepsin inhibitor 1 |
Cathepsin Inhibitor 1 |
225120-65-0 |
详细
|
| Epitinib succinate |
琥珀酸EPITINIB |
2252334-12-4 |
详细
|
| DDO-7263 |
化合物DDO-7263 |
2254004-96-9 |
详细
|
| ZX-29 |
ZX-29 |
2254805-62-2 |
详细
|
| 2-Phenylethyl isothiocyanate |
2-苯基乙基异硫代氰酸酯 |
2257-09-2 |
详细
|
| STING agonist-12 |
STING AGONIST-12 |
2259624-71-8 |
详细
|
| Cyclothiazide |
莰烯氯噻嗪 |
2259-96-3 |
详细
|
| Monaschromone |
苦楝萜酮内酯 |
22611-36-5 |
详细
|
| SM-360320 |
6-氨基-7,9-二氢-2-(2-甲氧基乙氧基)-9-(苯甲基)-8H-嘌呤-8-酮 |
226907-52-4 |
详细
|
| Tuspetinib |
化合物HM43239 |
2294874-49-8 |
详细
|
| FLT3-IN-4 |
FLT3-IN-4 |
2304799-09-3 |
详细
|
| IU1-248 |
Benzonitrile, 4-[3-[2-(4-hydroxy-1-piperidinyl)acetyl]-2,5-dimethyl-1H-pyrrol-1-yl]- |
2307472-03-1 |
详细
|
| Matairesinoside |
罗汉松脂苷 |
23202-85-9 |
详细
|
| HPK1-IN-7 |
1(3H)-Isobenzofuranone, 5-[[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-5-(1,3,4-oxadiazol-2-yl)-2-pyrimidinyl]amino]-3,3-dimethyl- |
2320462-65-3 |
详细
|
| MAGL-IN-1 |
MAGL-IN-1 |
2324160-91-8 |
详细
|
| ACSS2-IN-2 |
化合物ACSS2-IN-2 |
2332820-04-7 |
详细
|
| PARP/PI3K-IN-1 |
CAY10749 |
2337386-47-5 |
详细
|
| Djalonensone |
交链孢霉甲基醚 |
23452-05-3 |
详细
|
| 15-LOX-1 inhibitor 1 |
9C(I472) |
2349374-37-2 |
详细
|
| GA-017 |
化合物GA-017 |
2351906-74-4 |
详细
|
| Enbezotinib |
TPX-0046 |
2359649-81-1 |
详细
|
| RBN-3143 |
PARP14抑制剂 |
2360853-16-1 |
详细
|
| AES-135 |
AES-135 |
2361659-61-0 |
详细
|
| MS31 |
MS31 |
2366264-12-0 |
详细
|
| Zanzalintinib |
XL092 |
2367004-54-2 |
详细
|
| BRM/BRG1 ATP Inhibitor-2 |
化合物 BRM/BRG1 ATP INHIBITOR-2 |
2368900-77-8 |
详细
|
| G140 |
化合物G140 |
2369751-07-3 |
详细
|
| (S)-Sunvozertinib |
2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]- |
2370013-49-1 |
详细
|
| Evixapodlin |
(5S,5'S)-5,5'-((((5,5'-(2,2'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis(3-methoxypyrazine-5,2-diyl))bis(methylene))bis(azanediyl))bis(methylene))bis(pyrrolidin-2-one) |
2374856-75-2 |
详细
|
| M2N12 |
M2N12 |
2376577-06-7 |
详细
|
| SU056 |
|
2376580-08-2 |
详细
|
| Migoprotafib |
抑制剂 |
2377352-49-1 |
详细
|
| BAY-3827 |
BAY-3827 |
2377576-35-5 |
详细
|
| SCR130 |
1,7,9-Triazaspiro[4.5]dec-1-ene-6,10-dione, 2,4-bis(4-chlorophenyl)-8-thioxo- |
2377858-38-1 |
详细
|
| PD-1/PD-L1-IN-NP19 |
化合物PD-1/PD-L1-IN-NP19 |
2377916-66-8 |
详细
|
| HWL-088 |
HWL-088 |
2378617-96-8 |
详细
|
| Reverse transcriptase-IN-1 |
Reverse transcriptase-IN-1 |
2380001-43-2 |
详细
|
| Nampt-IN-5 |
化合物NAMPT-IN-5 |
2380013-17-0 |
详细
|
| PF-07220060 |
CDK4/6-IN-6 |
2380321-51-5 |
详细
|
| NF-κΒ activator 1 |
|
2387524-59-4 |
详细
|
| JAK2/FLT3-IN-1 |
JAK2/FLT3-IN-1 |
2387765-27-5 |
详细
|
| Anhydroerythromycin A |
脱水红霉素 |
23893-13-2 |
详细
|
| EB-42486 |
化合物EB-42486 |
2390475-81-5 |
详细
|
| Pumecitinib |
|
2401057-12-1 |
详细
|
| ATX inhibitor 5 |
ATX inhibitor 5 |
2402772-45-4 |
详细
|
| Geranylgeraniol |
香叶基香叶醇 |
24034-73-9 |
详细
|
| MARK4 inhibitor 1 |
MARK4 inhibitor 1 |
2271081-58-2 |
详细
|
| BAY 2666605 |
化合物BAY 2666605 |
2275774-60-0 |
详细
|
| Maralixibat chloride |
HP-625) |
228113-66-4 |
详细
|
| Pratensein |
红车轴草素 |
2284-31-3 |
详细
|
| VULM 1457 |
VULM 1457 |
228544-65-8 |
详细
|
| E64FC26 |
E64FC26 |
2285446-62-8 |
详细
|
| Bractoppin |
Bractoppin |
2290527-07-8 |
详细
|